Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Spectral AI Posts Q2 Net Loss as Revenue Falls to $3.5 Million

None

Spectral AI (MDAI) reported second-quarter 2026 research and development revenue of $3.5 million, down from $5.1 million a year earlier. Net loss was $4.2 million, or $0.13 per basic and diluted share, compared with a net loss of $8.0 million, or $0.31 per basic and diluted share.

The company said it received FDA clearance in May 2026 for the DeepView System for Burn Indication and remains focused on first commercial sales in the U.S. by year end 2026. Cash and cash equivalents were $14.0 million as of June 30, 2026.

  • Q2 2026 research and development revenue was $3.5 million, compared with $5.1 million in Q2 2025.
  • Q2 2026 net loss was $4.2 million, compared with $8.0 million a year earlier.
  • Gross margin was 31.6%, down from 45.2%.
  • Operating expenses rose 23.2% to $5.4 million.
  • The company reiterated 2026 revenue guidance of approximately $18.5 million.
  • Spectral AI drew $6.5 million under its Avenue Capital Group credit facility after FDA clearance.
EARLY ACCESS
Receive MDAIW Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

$MDAIW Hedge Fund Activity

We have seen 1 institutional investors add shares of $MDAIW stock to their portfolio, and 4 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles